NEXTURNBIOSCIENCE Co., Ltd. (KOSDAQ:089140)

NEXTURNBIOSCIENCE Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2010
Period Ending	Mar 21, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2010
Market Capitalization	31,763	51,872	65,856	200,064	124,142	27,910
Market Cap Growth	-39.85%	-21.23%	-67.08%	61.16%	344.80%	23.07%
Enterprise Value	77,124	86,701	126,455	191,439	117,721	21,975
Last Close Price	2535.00	5520.00	8475.00	31200.00	19833.33	4636.10
PE Ratio	-	5.36	-	-	-	11.16
PS Ratio	0.88	1.26	2.81	11.79	12.82	1.11
PB Ratio	0.22	0.38	0.61	2.16	1.28	1.29
P/TBV Ratio	0.24	0.38	0.63	2.16	1.29	1.30
P/FCF Ratio	-	-	62.58	-	-
P/OCF Ratio	-	-	54.60	526.16	-
EV/Sales Ratio	2.44	2.10	5.39	11.28	12.15	0.88
EV/EBITDA Ratio	136.00	118.47	-	-	-	6.51
EV/EBIT Ratio	-	-	-	-	7.32
EV/FCF Ratio	-43.14	-	-	59.88	-	-
Debt / Equity Ratio	0.57	0.56	0.70	0.31	0	-
Debt / EBITDA Ratio	90.78	104.90	-	-	-	-
Debt / FCF Ratio	-	-	-	8.88	-	-
Asset Turnover	0.14	0.19	0.14	0.14	-	-
Inventory Turnover	3.59	4.84	2.93	1.98	-	-
Quick Ratio	1.55	0.41	1.84	1.05	27.58	-
Current Ratio	2.10	0.50	2.23	1.18	32.29	-
Return on Equity (ROE)	-15.51%	7.53%	-4.85%	-4.68%	-	12.05%
Return on Assets (ROA)	-0.26%	-0.36%	-1.67%	-1.25%	-	-
Return on Capital (ROIC)	-0.29%	-0.40%	-1.86%	-1.37%	-	9.04%
Earnings Yield	-40.94%	18.66%	-7.12%	-2.22%	-1.96%	8.96%
FCF Yield	-5.63%	-5.88%	-2.14%	1.60%	-0.79%	-
Buyback Yield / Dilution	-21.97%	-48.59%	-5.86%	-	-	-
Total Shareholder Return	-21.97%	-48.59%	-5.86%	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.